Asunción, Paraguay – Pharmaceutical companies and medical suppliers in Paraguay are seeking to recover over $1.2 billion in outstanding debts owed by the government through a proposed legislative change. The move, spearheaded by industry groups, aims to broaden the scope of a debt assignment mechanism, potentially unlocking funds crucial for the continued supply of medications and medical equipment to the nation’s healthcare system. The situation highlights the ongoing financial strain within Paraguay’s public health sector and the challenges of balancing government budgets with the needs of essential healthcare providers.
The core of the dispute centers around a restriction known as “subgroup 350,” which currently limits the utilize of debt assignment – a financial tool allowing the government to transfer its debt obligations to financial institutions – exclusively to pharmaceutical products. Industry representatives argue this limitation significantly underestimates the total debt owed and hinders their ability to receive full payment. The proposed legislation seeks to remove this restriction, allowing debt assignment to be applied to all 102 expenditure items utilized by the Ministry of Health, effectively “clarifying” the total debt, which currently stands at more than $1.2 billion. Of that amount, approximately $775 million is specifically for pharmaceuticals, according to industry estimates.
Debt Assignment and the Proposed Changes
Debt assignment, allows the government to settle its debts by transferring the obligation to a bank or financial institution. The supplier then receives payment from the bank, often at a discounted rate, but with quicker access to funds than waiting for direct government payment. The current restriction to “subgroup 350” means that only debts related to medications can be handled this way, leaving a substantial portion of outstanding invoices unpaid. Rocío Figueroa, spokesperson for the Chamber of Representatives of Importers of Pharmaceutical Products (CRIPFA), explained that the proposed change would allow for a more comprehensive approach to debt resolution.
“We are going to proceed with the debt assignment once we have consolidated the figures,” Figueroa stated, according to reporting by ABC Color. “We will deliver [the consolidated figures] to the Ministry of Economy on April 7th. We hope that banks will too reach forward to totalize and pay the debt; the State must pay the bank interest on this assignment because it can no longer pay the companies interest upon interest.”
Impact on Paraguay’s Healthcare System
The delayed payments have created significant challenges for pharmaceutical companies and medical suppliers, impacting their ability to maintain consistent supply chains and invest in modern products. This, in turn, can affect the availability of essential medications and medical equipment for public hospitals and clinics. The situation is particularly concerning given Paraguay’s ongoing efforts to strengthen its healthcare infrastructure and improve access to care for its citizens. A reliable supply of pharmaceuticals is fundamental to these efforts.
The financial strain on the healthcare sector isn’t new. Paraguay has historically faced budgetary constraints that impact its ability to promptly settle debts with healthcare providers. The COVID-19 pandemic further exacerbated these challenges, increasing demand for medical supplies while simultaneously straining government finances. The proposed debt assignment modification is seen by industry leaders as a critical step towards stabilizing the situation and ensuring the long-term sustainability of the healthcare supply chain.
Stakeholder Perspectives
While the pharmaceutical companies and suppliers are advocating for the legislative change, the government’s position remains cautious. Concerns have been raised about the potential impact of expanding debt assignment on the national budget and the overall debt burden. The Ministry of Economy is expected to carefully review the proposal and assess its financial implications before making a decision. Negotiations between the government and industry representatives are ongoing, with both sides seeking a solution that addresses the outstanding debt while safeguarding the country’s fiscal stability.
The Paraguayan Banking Association has also expressed interest in the proposal, recognizing the potential for increased business through debt assignment. However, banks are likely to demand favorable terms and guarantees to mitigate the risk associated with assuming government debt. The success of the initiative will depend on reaching an agreement that satisfies all stakeholders.
Next Steps and Timeline
The industry groups plan to formally submit the consolidated debt figures to the Ministry of Economy on April 7, 2026. Following the submission, the Ministry will conduct its review and engage in further discussions with industry representatives and banking officials. A vote on the proposed legislative change in the National Congress is anticipated in the coming weeks, although the exact timeline remains uncertain. The outcome of the vote will determine whether the debt assignment mechanism can be broadened to include all healthcare-related expenditures, potentially unlocking much-needed funds for the pharmaceutical sector and improving the overall health of Paraguay’s public healthcare system.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute financial or legal advice. Readers should consult with qualified professionals for advice tailored to their specific circumstances.
What do you think about Paraguay’s approach to resolving this debt? Share your thoughts in the comments below, and please share this article with your network.
Worth a look
